Preview

Pfizer Industry Review

Best Essays
Open Document
Open Document
4325 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pfizer Industry Review
Pfizer Corporation: The pharmaceutical industry began in the early 1800’s when several chemical companies were founded in Philadelphia, marking the beginning of our current pharmaceutical manufacturing industry (Pfizer, 2008a). Founded in 1849, Pfizer has grown into a multibillion-dollar corporation by providing many of the highest quality drugs available today (Pfizer, 2007). However, many factors impact the continued success of Pfizer and the pharmaceutical industry in general. After reviewing these factors, it is our recommendation that Pfizer focus on short-term consolidation and long-term global expansion into emerging markets while focusing research and development efforts in the biotech sector.
Market Structure Since the 1950s, the global pharmaceutical industry has evolved from “…a collection of several hundred, small, barely profitable firms to as small group of large, highly profitable firms” (Younkin, 2008, para. 1). This evolution has resulted in an oligopoly market structure with a few large firms, and significant barriers to market entry. In the last 20 years, pharmaceutical consolidation has continued with both vertical and horizontal mergers that have further shrunk the market. Since 1995, Pfizer has merged with five pharmaceutical firms (Industry Brief, 2003) in an attempt to increase its research and development divisions and to offset declines in new product development; increases in generic competition; and the emergence of bio-pharmaceutical firms (BCC Research, 2004). Although pharmaceutical firms no longer view mega mergers as “…a cure-all for [their] innovation drought” (Simons, 2007, para. 1), this trend towards consolidation is expected to continue, with firms focusing “…on targeted acquisitions and alliances with smaller…more innovative drug makers and biotechs” (Simons, 2007, para. 10).
Competition
Competition is somewhat limited in oligopoly market structures due to the barriers to market entry. In the pharmaceutical industry,



References: BCC Research. (2004). World Pharmaceutical Market. Retrieved April 8, 2008, from http://www.marketwatch.com/news/story/pfizers-profit-plunges-generic-competition/story.aspx?guid=%7BFD4C07F3-9E1A-404E-BEA5-12E65CCD46A3%7D Business Week Congressional Budget Office. (1998). How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry Danzon, P. (2007). Regulation of the pharmaceutical-biotechnology industry Global Pharmaceutical Industry. (2007). Barriers to entry in the global industry. Retrieved March 26, 2008 from http://www.duke.edu/web/soc142/team2/social.html#pfizer Kermani, Falz. (2006). The healthcare market in Columbia. Retrieved April 11, 2008 from http://jobs.leaddiscovery.co.uk/resourcearticles.aspx?rid=48&t=The%20healthcare%20market%20in%20Colombia Industry Brief: Pharmaceuticals Lawler, Brian. (2007). Looking Forward at Pfizer. Retrieved April 11, 2008, from http://www.fool.com/investing/value/2007/09/11/looking-forward-at-pfizer.aspx Martino, M Owens, J. (2007). Big pharma slims down to bolster productivity. Retrieved March 28, 2008, from http://www.nature.com/nrd/journal/v6/n3/full/nrd2284.html;jsessionid=183ADD340B66202AFB2CA4A9D50FF4ED Pfizer. (2008a). A pioneering spirit on the frontiers of medicine. Retrieved March 19, 2008, from: http://www.pfizer.com/about/history/timeline.jsphttp://www.pfizer.com/about/history/timeline.jsp. Pfizer. (2008b). Research and development at Pfizer. Retrieved April 6, 2008, from http://www.pfizer.com/research/ Pfizer Pfizer (2007). 2007 Annual review. Retrieved March 19, 2008, from: http://media.pfizer.com/files/annualreport/2007/annual/review2007.pdfhttp://media.pfizer.com/files/annualreport/2007/annual/review2007.pdf. Philipson, T. & Sun, E. (2008). Regulating the safety and efficacy of prescription drugs PR-inside. ( 2008). Pfizer presents new opportunities for global growth. Retrieved April 4, 2008, from http://www.pr-inside.com/pfizer-presents-new-opportunities-for-global-growth-r471732.htm Research and Markets Rubin, A. (2006). "Branded" Generic Drugs. Retrieved April 11, 2008, from http://www.therubins.com/legal/branded.htm Saul, S Shaw, A. ( March 2008). Direct-to-Consumer Advertising of Pharmaceuticals. Retrieved April 3, 2008, from http://www.csa.com/discoveryguides/direct/review3.php Simons, J Stat-A-Matrix. (n.d.) What is the FDA vision for pharmaceutical development and manufacturing in the 21st Century? Retrieved April 3, 2008, from http://www.statamatrix.com/pharmaceuticals/pharmfaq.php The Associated Press U.S. Environmental Protection Agency. (n.d.) Economic Analysis for Final Effluent Limitations Guidelines and Standards: Profile of the Pharmaceutical Industry. Retrieved April 10, 2008, from http://www.epa.gov/guide/pharm/econanal/econ-ch3.pdf U.S Younkin. (March 2008). Market: How the American pharmaceutical industry transformed itself during the 1940s. Retrieved April 6, 2008, from http://socrates.berkeley.edu/~iir/culture/papers/Younkin-Mar08.pdf

You May Also Find These Documents Helpful

  • Best Essays

    The Pharmaceutical industry has been around since the Middle Ages, and it has affected healthcare in many ways. The development of medicine and having a scientific approach, while being able to understand the human biology such as DNA, has helped achieve miracles. One of the most well known pharmaceutical companies Pfizer has grown since 1849 when it was founded, and they have taken great measurements to achieve success in this field (Pfizer, 2010). They invested much of their shareholder’s money to create penicillin at a faster rate to help war victims during the war (Pfizer, 2010). Although there has been a vast variety of competition in the 21st century, the pharmaceutical industry during the 20th century did not have much competition and doctors did not mind as much to pay x amount of money for drugs. Patients were not well informed, and counted on their doctor to provide them with the correct treatment (A Recent History, 2007). From the beginning of time this industry has helped patients live longer and has transformed healthcare.…

    • 4398 Words
    • 18 Pages
    Best Essays
  • Powerful Essays

    Pfizer Analysis

    • 1396 Words
    • 6 Pages

    Jarvis, L. (2005, October 21). Pfizer faces challenges to growth. Chemical Market Reporter, 266, p. 10.…

    • 1396 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    Strategy: Pfizer is the world’s number one pharmaceutical company. Its best-selling products include Lipitor, the world’s best- selling medicine, and eight of the top twenty-five medicines in the world. Acquisition of successful competitors such as Pharmacia and Warner Lambert has helped Pfizer to offer best-selling products and further differentiate itself from competitors. The acquisition of the latter company helped bring Lipitor under Pfizer’s control.…

    • 3675 Words
    • 15 Pages
    Powerful Essays
  • Good Essays

    Pfizer - Financial Analysis

    • 2555 Words
    • 11 Pages

    Pfizer (NYSE: PFE) is involved in the development, manufacturing and marketing of pharmaceutical products. The industry is intensely competitive. There are a few unique characteristics. Pharmaceutical products have long and expensive development periods – upwards of ten years and $100 million depending on the nature of the drug and the scope of the clinical trials process. In order to encourage companies to engage in innovation, companies are given lengthy patent protection for their drugs upon receiving regulatory approval. This allows them to charge monopoly rents so that they may recover the development cost. A product brought to market is often highly lucrative, so success in the industry depends largely on the firm’s ability to bring product to market and capitalize on the monopoly rents.…

    • 2555 Words
    • 11 Pages
    Good Essays
  • Good Essays

    Pharmaceuticals. Southern Economic Journal, 59(2), 165. Retrieved October 27, 2009, from ABI/INFORM Global. (Document ID: 801714). http://proquest.umi.com.ezproxy2.apus.edu/pqdweb?index=10&did=801714&SrchMode=1&sid=3&Fmt=6&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1256670172&clientId=62546…

    • 743 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Strategic Management

    • 6750 Words
    • 27 Pages

    Global pharmaceuticals grew by 3.6% in 2010 to reach over $733 billion with projections reaching $981 billion by the year 2015 (Pharmaceuticals Industry Profile: Global, 2011). Pfizer, the world leader in the global pharmaceuticals market, controls an impressive 9.4% of the global market share (Pharmaceuticals Industry Profile: Global, 2011). Sometimes described as Frankenstein’s Monster, Pfizer has been aggressively swallowing up smaller companies since the early 1990’s to become the present day drug giant. Pfizer along with other companies will be facing a fork in the road in the near future as they exit their blockbuster growth with the expiration of many of the company’s most successful drug patents. In this paper we will conduct several analyses to identify strategies that would be viable options for the company. Pfizer, which has been a company that has dominated with its inorganic growth in the past (Appendix N), will now have to decide…

    • 6750 Words
    • 27 Pages
    Powerful Essays
  • Good Essays

    Pfizer Overview

    • 550 Words
    • 3 Pages

    Pfizer Incorporated is a major pharmaceutical company and is one of the leading in the world for pharmaceutical sales It currently has the largest Research and Development department out of any Bio-medical company in the world. Some of the products that Pfizer produces that readers might be familiar with are: Lipitor (atorvastatin); oral antifungal medication Diflucan (fluconazole), another popular antibiotic Zithromax commonly reffered to as a the “Z” pack (azithromycin), the well-known erectile dysfunction drug Viagra (sildenafil citrate), and the anti inflammatory drug Celebrex (celecoxib)…

    • 550 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Pfizer Inc. is a large pharmaceutical company that engages in the discovery of new technologies, the manufacture of prescription and "over the counter" (OTC) medicines, as well as the marketing of such products. It operates in three distinct segments that include Human Health, Consumer Healthcare, and Animal Health. For fiscal year 2004, the company generated approximately $53 billion in revenue that contributed to over $11 billion in net income. (Pfizer, 2004)…

    • 1018 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Horizontal Analysis Paper

    • 1394 Words
    • 6 Pages

    Pfizer is Pfizer is the world’s leading pharmaceutical company with more than 122,000 employees worldwide and operations in over 150 countries. . Throughout the years, Pfizer has continued to discover, develop and bring to market innovative medicines that treat diseases and improve the quality of patients’ lives. In 2001, they adopted a new mission to…

    • 1394 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    Drug manufacturers need to regain access to these markets to protect themselves in a dynamic industry. In just a few years, from the early to the mid-1990s, the healthcare industry witnessed dramatic changes within its supply chain. Even if a merger did not bring about short term profits, like Eli Lilly and PCS, it still eliminates a deadly threat. Merck’s competitors were gaining ground by being placed on Medco formularies (Pg.16). If one of these companies were to get complete control, it could replace most of Merck’s products with its own. In a way, this acquisition was an investment to properly position Merck in an unpredictable future. If this future held a system in which the most drugs were sold through PBMs, or not, Merck would be positioned to continue their successful business. As one Merck-Medco put it “Our business is constantly changing.” (Pg. 19). This merger had to occur to create a company flexible and agile enough to adapt to a changes.…

    • 692 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Analysis of the Medicines Company case revealed several critical aspects that need to be addressed. The pharmaceutical industry can be very profitable, but is also very risky. As described in the case, bringing a new drug to market is a costly and lengthy process requiring an average of 10 years. Big Pharmaceutical companies struggle to keep upcoming drugs in their pipeline to provide revenue when existing drugs come off patent and are replaced by generic compounds. With 1 in 4000 compounds making it to market, there is significant risk of failure that can be reduced by having many compounds in development. Additionally, a drug company's reputation can easily be tarnished by safety issues with a compound, dramatically affecting their sales.…

    • 2114 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    Generic brands have been profitable and cost efficient for buyers. This simply means that suppliers don’t need to offer a particular name brand; all they need have is the active ingredients that brand name suppliers that have the same function as name brand medications.…

    • 512 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    Merck Business Analysis

    • 1943 Words
    • 8 Pages

    The global pharmaceutical market is likely to undergo a wide variety of changes with new competition arising in India, China, Malaysia, South Korea, and Indonesia. This new competition has a growing economy and has made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States.…

    • 1943 Words
    • 8 Pages
    Powerful Essays
  • Powerful Essays

    Paper - Wyeth

    • 1877 Words
    • 8 Pages

    The pharmaceutical-biotechnology industry has become increasingly consolidated over the past 15 years; in 1985 the 10 largest firms accounted for about 20 percent of worldwide sales, whereas in 2002 the 10 largest firms accounted for 48 of sales. Much of this consolidation is the result of mergers. The value of M&A activity in this industry exceeded $500 billion during the 1988 to 2000 period. A…

    • 1877 Words
    • 8 Pages
    Powerful Essays
  • Powerful Essays

    Merck Case Study

    • 6941 Words
    • 28 Pages

    Hsu, H. C. (2010). Using MSN money to perform financial ratio analysis. Journal of College Teaching and Learning, 7(9), 25-35. doi: 751262328.…

    • 6941 Words
    • 28 Pages
    Powerful Essays